Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

LLY

Lilly(Eli) & Co

Mar 27 • 04:00PM ET

821.67

Dollar change -5.09
Percentage change -0.62	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: PFE MRK JNJ BMY GILD AMGN ABBV REGN BIIB VRTX

| Held by: VTI VOO VUG IVV SPY XLV IWF VHT QUAL IVW

Scroll to Statements

Index	S&P 500	P/E	71.52	EPS (ttm)	11.49	Insider Own	10.34%	Shs Outstand	947.54M	Perf Week	-2.48%
Market Cap	778.93B	Forward P/E	27.78	EPS next Y	29.58	Insider Trans	-0.89%	Shs Float	849.99M	Perf Month	-10.20%
Income	10.59B	PEG	1.72	EPS next Q	4.69	Inst Own	72.97%	Short Float	0.75%	Perf Quarter	3.19%
Sales	45.04B	P/S	17.29	EPS this Y	78.06%	Inst Trans	-5.51%	Short Ratio	1.75	Perf Half Y	-11.12%
Book/sh	14.98	P/B	54.86	EPS next Y	27.89%	ROA	14.84%	Short Interest	6.36M	Perf Year	6.28%
Cash/sh	3.61	P/C	227.55	EPS next 5Y	41.64%	ROE	84.84%	52W Range	711.40 - 972.53	Perf YTD	6.43%
Dividend Est.	6.58 (0.80%)	P/FCF	207.16	EPS past 5Y	18.77%	ROI	24.79%	52W High	-15.51%	Beta	0.49
Dividend TTM	5.40 (0.66%)	Quick Ratio	0.89	Sales past 5Y	15.54%	Gross Margin	81.31%	52W Low	15.50%	ATR (14)	24.30
Dividend Ex-Date	Feb 14, 2025	Current Ratio	1.15	EPS Y/Y TTM	102.18%	Oper. Margin	37.83%	RSI (14)	43.13	Volatility	2.83% 2.98%
Employees	47000	Debt/Eq	2.37	Sales Y/Y TTM	32.00%	Profit Margin	23.51%	Recom	1.50	Target Price	1025.02
Option/Short	Yes / Yes	LT Debt/Eq	2.01	EPS Q/Q	101.79%	Payout	44.39%	Rel Volume	0.58	Prev Close	826.76
Sales Surprise	0.44%	EPS Surprise	5.45%	Sales Q/Q	44.68%	Earnings	Feb 06 BMO	Avg Volume	3.63M	Price	821.67
SMA20	-3.87%	SMA50	-2.30%	SMA200	-4.02%	Trades		Volume	2,099,685	Change	-0.62%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025
Feb-21-24	Downgrade	DZ Bank	Buy → Hold	$820
Feb-16-24	Reiterated	Morgan Stanley	Overweight	$805 → $950
Dec-21-23	Downgrade	Daiwa Securities	Buy → Outperform	$660 → $610
Nov-09-23	Initiated	Deutsche Bank	Hold	$535
Oct-20-23	Resumed	UBS	Buy	$612 → $710
Aug-09-23	Upgrade	Jefferies	Hold → Buy	$408 → $615
Jul-26-23	Reiterated	Citigroup	Buy	$360 → $525
Jul-14-23	Initiated	HSBC Securities	Buy	$560
May-24-23	Reiterated	UBS	Buy	$447 → $498
May-24-23	Reiterated	BofA Securities	Buy	$450 → $500
Mar-13-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$360 → $375
Mar-06-23	Initiated	Jefferies	Hold	$290
Feb-15-23	Downgrade	Societe Generale	Hold → Sell
Nov-18-22	Initiated	Credit Suisse	Outperform	$395
Sep-22-22	Upgrade	UBS	Neutral → Buy	$335 → $363

Show Previous Ratings

Today 08:47PM	Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q4 2024 Update (SeekingAlpha)
08:39PM	VIG: Index Rebalance Adds Eli Lilly To Bolster Dividend Growth In 2025 (SeekingAlpha)
06:36PM	Why Novo Nordisk Stock Dipped on Thursday (Motley Fool)
03:50PM	Eli Lilly and Company (LLY): Among Dividend Zombies to Invest in (InsiderMonkey)
01:29PM	Novo shares on track for biggest monthly fall since 2002, investor worries grow (Reuters)
11:15AM	Loading…
11:15AM	Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimers (Quartz)
10:50AM	Columbia Select Large Cap Growth Fund Q4 2024 Commentary (SeekingAlpha)
10:00AM	1 Growth Stock Down 40% to Buy and Hold Forever (Motley Fool)
09:15AM	Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025 (Motley Fool)
09:00AM	LillyDirect platform expands to facilitate access to Alzheimer's disease care (PR Newswire)
08:31AM	VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug (Zacks)
08:30AM	Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements (GlobeNewswire)
08:05AM	Organovo Provides Business Update (GlobeNewswire)
07:30AM	Price Targets Show These 3 Stocks Near the $1 Trillion Mark (MarketBeat)
Mar-26-25 05:04PM	Eli Lilly's GLP-1 pill could be the next key in obesity treatment (Yahoo Finance Video)
04:27PM	Loading…
04:27PM	Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study (Investor's Business Daily)
04:13PM	US is only country debating GLP-1 insurance coverage for weight loss: Cigna CEO Cordani (Yahoo Finance)
02:55PM	Franklin Growth Opportunities Fund Q4 2024 Commentary (SeekingAlpha)
02:41PM	Eli Lilly and Company (LLY): One of Two Sigma Investments' Top Stock Picks (InsiderMonkey)
10:17AM	The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs (SeekingAlpha)
08:00AM	The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors (Business Wire)
07:43AM	SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study (Zacks)
06:05AM	2 No-Brainer Growth Stocks to Buy and Hold Forever (Motley Fool)
03:20AM	Foghorn: SMARCA4 Targeting Brings About Treating Up To 10% Of NSCLC Patients (SeekingAlpha)
Mar-25-25 08:59PM	Tracking Lone Pine Capital Portfolio - Q4 2024 Update (SeekingAlpha)
05:45PM	Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why (Zacks)
04:35PM	Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
02:26PM	GLP-1s are driving returns on R&D investments for Big Pharma, report says (Quartz)
12:04PM	Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2% (Zacks)
12:01PM	Novo Nordisk earmarks $2bn for Chinese triple G weight loss shot (Pharmaceutical Technology)
11:25AM	Loading…
11:25AM	Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company (GlobeNewswire)
09:43AM	Is Eli Lilly and Company (NYSE:LLY) The Best Stocks to Buy Now For the Long Term? (InsiderMonkey)
08:03AM	Trump tariffs drive pharma manufacturing to US but risk inflation and disruption (Pharmaceutical Technology)
07:28AM	Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts (SeekingAlpha)
12:00AM	GLP-1s boosts pharma R&D projected return on investment: Deloitte (Yahoo Finance)
12:00AM	GLP-1s boost pharma R&D projected return on investment: Deloitte (Yahoo Finance)
Mar-24-25 04:17PM	Novo Nordisk Finds A New Way To Rival Eli Lilly. But Shares Tumble. (Investor's Business Daily)
03:06PM	BlackRock Advantage Large Cap Core Fund Q4 2024 Commentary (SeekingAlpha)
01:25PM	Hyundai to invest $20B in US manufacturing (Fox Business)
12:44PM	Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped (Motley Fool)
12:19PM	Novo Nordisk's $2 billion obesity deal (CNBC TV)
11:59AM	Was Jim Cramer Right About Eli Lilly and Company (LLY)? (InsiderMonkey)
11:05AM	Novo Nordisk Down 15% in March: Is This a Buying Opportunity? (Zacks)
10:59AM	BlackRock Capital Appreciation V.I. Fund Q4 2024 Commentary (SeekingAlpha)
09:15AM	Is Eli Lilly and Company (LLY) The Best Healthcare Dividend Stock to Invest in? (InsiderMonkey)
08:45AM	Watch These 5 AI-Powered Healthcare Bigwigs for Portfolio Gains (Zacks)
08:02AM	Novo adds to obesity drug pipeline via $200M deal with China-based biotech (BioPharma Dive)
08:00AM	Market Sell-Off: Can Buying These 3 "Safe" Stocks Today Set You Up for Life? (Motley Fool)
06:29AM	J&J to Invest $55B in United States to Boost Manufacturing, R&D (Zacks)
04:00AM	Lilly, Novo expand DTC reach of obesity meds after compound win (Pharma Voice)
Mar-23-25 09:59PM	BlackRock Sustainable Advantage Large Cap Core Fund Q4 2024 Commentary (SeekingAlpha)
12:00PM	Lantheus Holdings: One Blockbuster, Evolving Pipeline (SeekingAlpha)
07:26AM	Was Jim Cramer Right About Eli Lilly and Company (LLY)? (InsiderMonkey)
07:19AM	AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market (MarketBeat)
04:43AM	Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly (Motley Fool)
Mar-22-25 01:43PM	Is Eli Lilly and Company (LLY) The Best Robinhood Stock to Buy According to Analysts? (InsiderMonkey)
Mar-21-25 02:41PM	Johnson & Johnson is the latest pharma giant to court Trump with new investment plans (Quartz)
12:16PM	Accenture reports Q2 beat, Apple TV+ losing $1B annually: Morning Buzz (TipRanks)
11:17AM	Eli Lilly Reverses Its Recent Upswing On Broader Market Woes. Is It A Sell? (Investor's Business Daily)
10:17AM	Eli Lilly launches weight-loss drug Mounjaro in India, Reuters says (TipRanks)
09:38AM	Eli Lilly: Growth With Higher Margins (SeekingAlpha)
09:30AM	3 of Goldman Sachs' best investing tips for currently volatile markets (Yahoo Finance)
08:30AM	Artisan International Small-Mid Fund Q4 2024 Commentary (SeekingAlpha)
08:28AM	J&J's Tremfya Gets FDA Nod for 2nd IBD Condition Crohn's Disease (Zacks)
08:09AM	The Mag 7 Are Dead Money. 6 Megacap Stocks to Buy Instead. (Barrons.com)
07:21AM	Merck Vs. Bristol-Myers Squibb: Which Pharma Stock Should You Buy (SeekingAlpha)
Mar-20-25 10:13PM	BlackRock Tactical Opportunities Fund Q4 2024 Commentary (SeekingAlpha)
08:01PM	Tracking Philippe Laffont's Coatue Management Portfolio - Q4 2024 Update (SeekingAlpha)
02:17PM	6 Megacap Stocks to Buy That Arent the Mag 7 (Barrons.com)
01:03PM	3 Promising Biotechs Trading Substantially Under Consensus Analyst Firm Price Targets (SeekingAlpha)
12:06PM	Factbox-Lilly's weight-loss drug launch in India to energize rivals eyeing mega market (Reuters)
10:32AM	GSK Stock Recovers, Rises Around 17% YTD: Time to Buy, Sell or Hold? (Zacks)
10:10AM	BlackRock Large Cap Focus Growth Fund Q4 2024 Commentary (SeekingAlpha)
09:20AM	Invesco American Franchise Fund Q4 2024 Commentary (SeekingAlpha)
09:05AM	Invesco Health Care Fund Q4 2024 Commentary (SeekingAlpha)
09:00AM	SPXE: Overtaking SPY Without Fuel (SeekingAlpha)
08:20AM	Eli Lilly launches weight loss drug in India beating Novo Nordisk (SeekingAlpha)
06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
05:25AM	5 Reasons It's Not Too Late to Buy Eli Lilly Stock (Motley Fool)
02:54AM	Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market (Reuters)
Mar-19-25 11:54AM	Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Arent Happy. (The Wall Street Journal)
09:47AM	Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity (Insider Monkey)
09:01AM	3 Market-Beating Stocks to Target This Week (StockStory)
08:29AM	Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks (Investor's Business Daily)
03:06AM	Unlocking Intrinsic Value: Analysis of Eli Lilly and Co (GuruFocus.com)
Mar-18-25 05:45PM	Eli Lilly (LLY) Stock Moves -0.27%: What You Should Know (Zacks)
05:06PM	Eli Lilly And Company (LLY): Among Stocks to Buy That May Be Splitting Soon (Insider Monkey)
01:39PM	Is Eli Lilly and Company (LLY) the Best Diabetes Stock to Buy According to Billionaires? (Insider Monkey)
08:48AM	Jim Cramer Says Eli Lilly And Co (LLY) Sellers Are Uninformed (Insider Monkey)
08:45AM	Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? (MarketBeat)
Mar-17-25 12:05PM	Trump Tariffs and the Nasdaq Correction Have Been No Match for These Stock Market Sectors (Motley Fool)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
06:47AM	3 Unstoppable Stocks You Can Buy Now Without Any Hesitation (Motley Fool)
05:00AM	The weight loss drug shortage is over and some patients are 'panicking' (Quartz)
01:00AM	Irelands Profits From Weight-Loss Drugs Draw Trumps Attention (Bloomberg)
Mar-16-25 10:54AM	Jim Cramer Says: Keep an Eye on Eli Lilly and Company (LLY) (Insider Monkey)
05:00AM	Fix the NHS or miss out on our money, US drug giant warns Britain (The Telegraph)
Mar-15-25 09:00AM	Tesla's problems, Eli Lilly's weight loss pill, and egg prices surge: Business news roundup (Quartz)
Mar-14-25 10:26PM	Is Eli Lilly and Company (LLY) the Best Quality Stock to Invest in Now? (Insider Monkey)
04:02PM	AstraZeneca Stock Scores RS Rating Upgrade (Investor's Business Daily)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 10 '25	Sale	863.21	5,000	4,316,065	117,888	Feb 12 04:15 PM
Skovronsky Daniel	Officer	Feb 10 '25	Proposed Sale	863.19	5,000	4,315,954		Feb 10 11:44 AM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Sale	874.13	210,000	183,567,262	96,681,978	Feb 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 06 '25	Proposed Sale	842.18	210,000	176,857,800		Feb 06 04:04 PM
Yuffa Ilya	EVP & President, LLY Int'l	Feb 01 '25	Option Exercise	0.00	3,269	0	23,071	Feb 04 04:28 PM
White Anne E.	EVP & Pres, Lilly Neuroscience	Feb 01 '25	Option Exercise	0.00	3,269	0	68,838	Feb 04 04:27 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Feb 01 '25	Option Exercise	0.00	3,023	0	14,868	Feb 04 04:26 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Feb 01 '25	Option Exercise	0.00	8,989	0	126,892	Feb 04 04:25 PM
Ricks David A	President, Chair, and CEO	Feb 01 '25	Option Exercise	0.00	26,561	0	496,385	Feb 04 04:24 PM
Rau Diogo	EVP & CIDO	Feb 01 '25	Option Exercise	0.00	3,269	0	14,370	Feb 04 04:23 PM
Jonsson Patrik	EVP&Pres, CardMetHlth, LLY USA	Feb 01 '25	Option Exercise	0.00	3,433	0	48,016	Feb 04 04:23 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '25	Option Exercise	0.00	2,861	0	33,479	Feb 04 04:21 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '25	Option Exercise	0.00	4,904	0	20,683	Feb 04 04:19 PM
Zakrowski Donald A	Officer	Nov 08 '24	Proposed Sale	803.38	900	723,042		Nov 08 04:54 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 08 '24	Sale	803.38	900	723,042	5,480	Nov 08 04:18 PM
Montarce Lucas	EVP & CFO	Nov 01 '24	Option Exercise	0.00	1,074	0	11,541	Nov 05 04:15 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Nov 01 '24	Option Exercise	0.00	1,687	0	31,369	Nov 05 04:14 PM
Dozier Eric	EVP, HR & Diversity	Nov 01 '24	Option Exercise	0.00	1,534	0	8,724	Nov 05 04:13 PM
LILLY ENDOWMENT INC	10% Owner	Sep 03 '24	Sale	966.69	24,084	23,281,840	96,891,978	Sep 04 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 27 '24	Sale	968.46	24,552	23,777,668	96,916,062	Aug 28 04:05 PM
Zakrowski Donald A	Officer	Aug 26 '24	Proposed Sale	950.00	750	712,500		Aug 26 04:47 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 26 '24	Sale	950.00	750	712,500	6,380	Aug 26 04:21 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Sale	966.33	3,196	3,088,382	96,940,614	Aug 23 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Aug 22 '24	Proposed Sale	951.97	215,000	204,673,550		Aug 22 12:54 PM
LILLY ENDOWMENT INC	10% Owner	Jul 10 '24	Sale	939.82	210,000	197,361,398	96,943,810	Jul 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 08 '24	Sale	918.64	93,593	85,977,954	97,153,810	Jul 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 05 '24	Sale	915.18	52,369	47,927,194	97,247,403	Jul 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 03 '24	Sale	915.31	8,848	8,098,655	97,299,772	Jul 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 01 '24	Sale	915.26	58,749	53,770,776	97,308,620	Jul 02 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 28 '24	Sale	915.02	1,441	1,318,545	97,367,369	Jul 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 25 '24	Sale	903.82	188,100	170,009,262	97,368,810	Jun 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 24 '24	Sale	902.38	17,229	15,547,068	97,556,910	Jun 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 20 '24	Sale	902.67	9,671	8,729,733	97,574,139	Jun 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 17 '24	Sale	885.91	194,978	172,733,708	97,583,810	Jun 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 14 '24	Sale	882.47	15,022	13,256,490	97,778,788	Jun 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 10 '24	Sale	860.78	75,510	64,997,274	97,793,810	Jun 11 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 07 '24	Sale	852.29	139,490	118,886,587	97,869,320	Jun 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 06 '24	Sale	837.82	179,617	150,485,878	98,008,810	Jun 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jun 05 '24	Sale	836.32	20,383	17,046,673	98,188,427	Jun 06 04:00 PM
Rau Diogo	EVP & CIDO	Jun 01 '24	Option Exercise	0.00	6,300	0	14,146	Jun 04 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Jun 03 '24	Sale	829.77	192,794	159,974,050	98,208,810	Jun 04 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Jun 03 '24	Sale	819.47	750	614,602	7,130	Jun 03 04:15 PM
Norton Johna	EVP, Global Quality	Jun 03 '24	Sale	819.38	7,056	5,781,545	25,428	Jun 03 04:14 PM
LILLY ENDOWMENT INC	10% Owner	May 31 '24	Sale	822.11	22,206	18,255,871	98,401,604	Jun 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 29 '24	Sale	811.04	130,385	105,747,975	98,423,810	May 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 28 '24	Sale	809.00	2,052	1,660,068	98,554,195	May 29 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 24 '24	Sale	809.21	92,563	74,902,998	98,556,247	May 28 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 23 '24	Sale	809.99	50,767	41,120,963	98,648,810	May 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 22 '24	Sale	804.18	12,974	10,433,483	98,699,577	May 23 04:00 PM
LILLY ENDOWMENT INC	10% Owner	May 21 '24	Sale	805.45	186,259	150,021,694	98,712,551	May 22 04:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

LLY

Lilly(Eli) & Co

Upgrade your FINVIZ experience